Cargando…

Functional Characterization of Pseudomonas Contact Dependent Growth Inhibition (CDI) Systems

Contact-dependent inhibition (CDI) toxins, delivered into the cytoplasm of target bacterial cells, confer to host strain a significant competitive advantage. Upon cell contact, the toxic C-terminal region of surface-exposed CdiA protein (CdiA-CT) inhibits the growth of CDI(-) bacteria. CDI(+) cells...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mercy, Chryslène, Ize, Bérengère, Salcedo, Suzana P., de Bentzmann, Sophie, Bigot, Sarah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4725963/ https://www.ncbi.nlm.nih.gov/pubmed/26808644 http://dx.doi.org/10.1371/journal.pone.0147435

Ejemplares similares

Correction: Functional Characterization of Pseudomonas Contact Dependent Growth Inhibition (CDI) Systems
por: Mercy, Chryslène, et al.
Publicado: (2016)

Identification of a Contact-Dependent Growth Inhibition (CDI) System That Reduces Biofilm Formation and Host Cell Adhesion of Acinetobacter baumannii DSM30011 Strain
por: Roussin, Morgane, et al.
Publicado: (2019)

Delivery of CdiA Nuclease Toxins into Target Cells during Contact-Dependent Growth Inhibition
por: Webb, Julia S., et al.
Publicado: (2013)

Identification of Functional Toxin/Immunity Genes Linked to Contact-Dependent Growth Inhibition (CDI) and Rearrangement Hotspot (Rhs) Systems
por: Poole, Stephen J., et al.
Publicado: (2011)

Genetic Evidence for SecY Translocon-Mediated Import of Two Contact-Dependent Growth Inhibition (CDI) Toxins
por: Jones, Allison M., et al.
Publicado: (2021)

A Type VI Secretion System Trans-Kingdom Effector Is Required for the Delivery of a Novel Antibacterial Toxin in Pseudomonas aeruginosa
por: Berni, Benjamin, et al.
Publicado: (2019)

Lipidation of Class IV CdiA Effector Proteins Promotes Target Cell Recognition during Contact-Dependent Growth Inhibition
por: Halvorsen, Tiffany M., et al.
Publicado: (2021)

Genome wide identification and experimental validation of Pseudomonas aeruginosa Tat substrates
por: Gimenez, Maxime Rémi, et al.
Publicado: (2018)

Class II contact‐dependent growth inhibition (CDI) systems allow for broad‐range cross‐species toxin delivery within the Enterobacteriaceae family
por: Virtanen, Petra, et al.
Publicado: (2019)

Contribution of the Twin Arginine Translocation system to the exoproteome of Pseudomonas aeruginosa
por: Ball, Geneviève, et al.
Publicado: (2016)

Expeditive synthesis of trithiotriazine-cored glycoclusters and inhibition of Pseudomonas aeruginosa biofilm formation
por: Smadhi, Meriem, et al.
Publicado: (2014)

Activity of a Synthetic Peptide Targeting MgtC on Pseudomonas aeruginosa Intramacrophage Survival and Biofilm Formation
por: Moussouni, Malika, et al.
Publicado: (2019)

CDI Systems Are Stably Maintained by a Cell-Contact Mediated Surveillance Mechanism
por: Ruhe, Zachary C., et al.
Publicado: (2016)

Pseudomonas aeruginosa Contact-Dependent Growth Inhibition Plays Dual Role in Host-Pathogen Interactions
por: Melvin, Jeffrey A., et al.
Publicado: (2017)

Dissecting the Machinery That Introduces Disulfide Bonds in Pseudomonas aeruginosa
por: Arts, Isabelle S., et al.
Publicado: (2013)

Burden of Clostridioides difficile infection (CDI) - a systematic review of the epidemiology of primary and recurrent CDI
por: Finn, Elaine, et al.
Publicado: (2021)

Doctor, my patient has CDI and should continue to receive antibiotics. The (unresolved) risk of recurrent CDI
por: Castro, Iván, et al.
Publicado: (2019)

Disruption of the Endothelial Barrier by Proteases from the Bacterial Pathogen Pseudomonas aeruginosa: Implication of Matrilysis and Receptor Cleavage
por: Beaufort, Nathalie, et al.
Publicado: (2013)

Contact-dependent growth inhibition systems in Acinetobacter
por: De Gregorio, Eliana, et al.
Publicado: (2019)

A point-prevalence study on community and inpatient Clostridioides difficile infections (CDI): results from Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI), July to November 2018
por: Viprey, Virginie F, et al.
Publicado: (2022)

Editorial: Protein Export and Secretion Among Bacterial Pathogens
por: Sana, Thibault G., et al.
Publicado: (2020)

JBoss Weld CDI for Java platform
por: Finnegan, Ken
Publicado: (2013)

Focusing stewardship to help tackle CDI
Publicado: (2020)

Introducing Jakarta EE CDI: Contexts and Dependency Injection for Enterprise Java Development
por: Saeed, Luqman
Publicado: (2020)

SMT19969 for Clostridium difficile infection (CDI): in vivo efficacy compared with fidaxomicin and vancomycin in the hamster model of CDI
por: Sattar, Abdul, et al.
Publicado: (2015)

684. Characteristics of Patients with Initial Clostridioides difficile Infection (CDI) That Are Associated With Increased Risk of Multiple CDI Recurrences
por: Guh, Alice, et al.
Publicado: (2023)

Disruption of the Pseudomonas aeruginosa Tat system perturbs PQS-dependent quorum sensing and biofilm maturation through lack of the Rieske cytochrome bc(1) sub-unit
por: Soh, Eliza Ye-Chen, et al.
Publicado: (2021)

Use of Electronic Data to Identify Risk Factors Associated with Clostridium difficile Infection (CDI) and to Develop CDI Risk Scores
por: Aukes, Laurie, et al.
Publicado: (2017)

Functional and Structural Diversity of Bacterial Contact-Dependent Growth Inhibition Effectors
por: Cuthbert, Bonnie J., et al.
Publicado: (2022)

Pro CDI 2 in Java EE 8: an in-depth guide to context and dependency injection
por: Beernink, Jan, et al.
Publicado: (2019)

Bezlotoxumab (BEZ) for Prevention of Clostridium Difficile Infection (CDI) Recurrence (rCDI): Outcomes in Patients with Substantial Renal Impairment (SRI)
por: Golan, Yoav, et al.
Publicado: (2017)

Fidaxomicin Preserves the Intestinal Microbiome During and After Treatment of Clostridium difficile Infection (CDI) and Reduces Both Toxin Reexpression and Recurrence of CDI
por: Louie, Thomas J., et al.
Publicado: (2012)

1211. Response to Fecal Microbiota Transplant (FMT) in Refractory Clostridioides difficile Infection (CDI) is Modest Compared to Recurrent CDI in Hospitalized Patients
por: Shin, Jae Hyun, et al.
Publicado: (2020)

Contact-dependent traits in Pseudomonas syringae B728a
por: Hernandez, Monica N., et al.
Publicado: (2021)

A gacS Deletion in Pseudomonas aeruginosa Cystic Fibrosis Isolate CHA Shapes Its Virulence
por: Sall, Khady Mayebine, et al.
Publicado: (2014)

A New Member of the Growing Family of Contact-Dependent Growth Inhibition Systems in Xenorhabdus doucetiae
por: Ogier, Jean-Claude, et al.
Publicado: (2016)

N-Heterocyclic carbene–carbodiimide (NHC–CDI) betaine adducts: synthesis, characterization, properties, and applications
por: Lamb, Jessica R., et al.
Publicado: (2021)

New advances in the treatment of Clostridium difficile infection (CDI)
por: Hedge, Dennis D, et al.
Publicado: (2008)

The burden of CDI in the United States: a multifactorial challenge
por: Feuerstadt, Paul, et al.
Publicado: (2023)

Pseudomonas aeruginosa Genome Evolution in Patients and under the Hospital Environment
por: Lucchetti-Miganeh, Céline, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_p6ivc2npbukaku2336fq64kfah